Enzolytics, Inc. (OTCMKTS:ENZC) Short Interest Up 28,550.0% in December

Enzolytics, Inc. (OTCMKTS:ENZC) was the recipient of a significant growth in short interest in December. As of December 31st, there was short interest totalling 57,300 shares, a growth of 28,550.0% from the December 15th total of 200 shares. Based on an average trading volume of 21,887,900 shares, the days-to-cover ratio is currently 0.0 days.

Enzolytics Stock Performance

Shares of ENZC opened at $0.00 on Monday. Enzolytics has a fifty-two week low of $0.00 and a fifty-two week high of $0.02.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.